The interaction of diabetes and cancer: Recognizing the common Risk and therapeutic implications

• Authors: Benchilo Ezung , Paul Agastian
• Languages of publication: EN

Abstracts

EN

Diabetes and cancer are two of the most common chronic illnesses in the world, and there is mounting evidence that their relationships are complicated. Liver, pancreatic, and colorectal cancer are among the cancers that people with diabetes are more likely to have. The present article examines the common risk factors that may underlie both disorders, including insulin resistance, chronic inflammation, and modified metabolic processes. Additionally, it looks at how diabetes medication impacts the course of cancer and vice versa, especially in relation to treatment results. Gaining an understanding of this interaction is essential for enhancing treatment and prevention methods as well as providing patients who have both disorders at the same time with better healthcare advice. With the potential for further study or clinical recommendations concentrating on the integrated care of people with both illnesses, this topic provides a thorough review.

Keywords

EN

Cancer; Diabetes; Disease; Global health

Discipline

• MEDICAL_BIOLOGY: MEDICAL BIOLOGY

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2025
• Volume: 61
• Issue: 2
• Pages: 94-104

Contributors

author

Benchilo Ezung

• Research Department of Plant Biology and Biotechnology, Loyola College, Chennai - 600034, Tamil Nadu, India

author

Paul Agastian

• Research Department of Plant Biology and Biotechnology, Loyola College, Chennai - 600034, Tamil Nadu, India

References

• [1] Murea M, Ma L, Freedman BI (2012). Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications. Rev. Diabet. Stud. 9, 6–22
• [2] Rossetti L, Giaccari A, andR. DeFronzo A (1990). Glucose toxicity. Diabetes Care 13, 610–630
• [3] Smeltzer S, Bare BG (1992). Overview of study on diabetes. Med. Surg. Nurs. Suzanne C. 10, 10221025
• [4] Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 103, 137–149
• [5] Lacroix IME, Li-Chan ECY (2014). Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: a natural approach to complement pharmacotherapy in the management of diabetes. Mol Nutr Food Res. 58, 61–78
• [6] Salsali A, Nathan M (2006). A review of types 1 and 2 diabetes mellitus and their treatment with insulin. Am. J. 13, 349–361
• [7] Oboh G, Puntel RL, Rocha JBT (2007). Hot pepper (Capsicum annuum, Tepin and Capsicum chinese, Habanero) prevents Fe2+-induced lipid peroxidation in brain - in vitro. Food Chem 102, 178–185
• [8] Rupasinghe HPV, Balasuriya N, Wang Y (2017). Prevention of type 2 diabetes by polyphenols of fruits. In: Kaïs H, Al-Gubory KH, Laher I, editors. Nutritional Antioxidant Therapies: Treatments and Perspectives. Springer, 447–466
• [9] Rao M, Sreenivasulu M, Chengaiah B, Reddy K, Chetty M (2010). Herbal medicines for diabetes mellitus: A review. Int. J. Pharm. Tech. Res. 2, 1883–1892
• [10] Ademiluyi AO, Oboh G (2013). Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (a-amylase and a-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp Toxicol Pathol. 65, 305–309
• [11] Ibrahim MA, Koorbanally NA, Islam MS (2014). Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (a-glucosidase and a- amylase) by Khaya Senegalensis. Acta Pharmaceutica. 64, 311–324
• [12] Striegel L, Kang B, Pilkenton SJ, Rychlik M, Apostolidis E (2015). Effect of black tea and black tea pomace polyphenols on a-glucosidase and a-amylase inhibition, relevant to type 2 diabetes prevention. Front Nutr. 2, 3
• [13] Buchholz T and Melzig MF (2016). Medicinal plants traditionally used for treatment of obesity and diabetes mellitus - screening for pancreatic lipase and a-amylase inhibition. Phytother Res. 30, 260–266
• [14] Lloyd-Jones D, Adams R, Carnethon M et al. (2009). Heart Disease and Stroke Statistics – 2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480–486
• [15] Ríos JL, Francini F, Schinella GR (2015). Natural products for the treatment of type 2 diabetes mellitus. Planta Med. 81, 975–994
• [16] Kooti W, Moradi M, Akbari S, Sharafi-Ahvazi N, Asadi Samani M, Ashtary-Larky D (2015). Therapeutic and pharmacological potential of Foeniculum vulgare Mill: A review. J. Herb Med Pharm. 4, 1–9
• [17] Afrisham R, Aberomand M, Ghaari M, Siahpoosh A, Jamalan M (2015). Inhibitory effect of Heracleum persicum and Ziziphus jujuba on activity of alpha-amylase. J. Bot. 2015, 824683
• [18] Durazzo A, D’Addezio L, Camilli E, Piccinelli R, Turrini A, Marletta L, Marconi S, Lucarini M, Lisciani S, Gabrielli P (2018). From plant compounds to botanicals and back: A current snapshot. Molecules. 23, 1844
• [19] Gupta P, and De A (2012). Diabetes mellitus and its herbal treatment. Int. J. Res. Pharm. Biomed. Sci. 3, 706–721
• [20] Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM (2010). The global burden of cancer: priorities for prevention. Carcinogenesis. 31, 100–110
• [21] Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. (2020). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. [Online]. Available: https://gco.iarc.fr/today (Accessed May 4, 2024).
• [22] Valko M, Rhodes CJ, Moncol J, Izakovic M, and Mazur M (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico Biological Interactions. 160, 1–40
• [23] Tyagi N, Sharma GN, Shrivastava B, Chaudhary N, and Sahu N (2017). Cancer: An Overview. International Journal of Research and Development in Pharmacy & Life Sciences. 6, 2740–2747
• [24] Shofian NM, Hamid AA, Osman A, Saari N, Anwar F, Pak Dek MS, et al. (2011). Effect of freeze-drying on the antioxidant compounds and antioxidant activity of selected tropical fruits. Int J Mol Sci. 12, 4678–4692
• [25] Kim HG, Song H, Yoon DH et al. (2010). Cordyceps pruinosa extracts induce apoptosis of HeLa cells by a caspase dependent pathway. Journal of Ethnopharmacology. 128, 342–351
• [26] Mandal S.K, Biswas R, Bhattacharyya S.S, et al. (2010). Lycopodine from Lycopodium clavatum extract inhibits proliferation of HeLa cells through induction of apoptosis via caspase-3 activation. European Journal of Pharmacology. 626, 115–122
• [27] Coseri S (2009). Natural products and their analogues as efficient anticancer drugs. Mini Rev Med Chem. 9, 560–571
• [28] Solowey E, Lichtenstein M, Sallon S, Paavilainen H, Solowey E, Haya Lorberboum-Galski (2014). Evaluating Medicinal Plants for Anticancer Activity. The Scientific World Journal 1-12, 721402
• [29] Al Doghaither HA, Omar UM, Rahimulddin SA, Al-Ghafari AB (2016). Cytotoxic Effects of Aqueous Extracts of Urtica urens on Most Common Cancer Types in Saudi Arabia. J Biol Sci. 16, 242–246
• [30] Cragg GM and Newman DJ (2005). Plants as a source of anti-cancer agents. J Ethnopharmacol. 100, 72–79
• [31] Li W, Liu Z, Fontana F, Ding Y, Liu D, Hirvonen JT, et al. (2018). Tailoring porous silicon for biomedical applications: from drug delivery to cancer immunotherapy. Adv Mater 30, 1703740
• [32] Kumar D, Basu S, Parija L et al. (2016). Curcumin and ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomedicine and Pharmacotherapy. 81, 31–37
• [33] Hyun TK, Kim H-C, Ko Y-J, Kim J-S (2016). Antioxidant, a-glucosidase inhibitory and anti-inflammatory effects of aerial parts extract from Korean crowberry (Empetrum nigrum var. Japonicum). Saudi J Biol Sci. 23, 181–188
• [34] Kooti W, Servatyari K, Behzadifar M, et al. (2017). Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study. Journal of Evidence-Based Complementary & Alternative Medicine. 22, 982–995
• [35] Ali S, Nasreen S, Safeer S, Andleeb S, Ejaz M, Bano S, Shakir H (2016). Medicinal plants as therapeutic agents for cancer treatment. Punjab University Journal of Zoology. 31, 295–305
• [36] Malinowsky K, Wolff C, Gündisch S, Berg D and Becker K (2015). Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues. Journal of Cancer. 2, 26–35
• [37] Shariatzadeh S, Hamta A, Soleimani M, Fallah Huseini H and Samavat S (2014). The Cytotoxic Effects of Silymarin on the 4T1 Cell Line Derived from BALB/c Mice Mammary Tumors. J. Med. Plants. 13, 55-65
• [38] Padhye S, Banerjee S, Ahmad A, Mohammad R, and Sarkar FH (2008). From here to eternity - the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer therapy. 6, 495–510
• [39] Khalife R, Hodroj MH, Fakhoury R, Rizk S (2016). Thymoquinone from Nigella sativa Seeds Promotes the Antitumor Activity of Noncytotoxic Doses of Topotecan in Human Colorectal Cancer Cells in Vitro. Planta medica. 82, 312–321
• [40] Nawab A, Yunus M, Mahdi A, and Gupta S (2011). Evaluation of Anticancer Properties of Medicinal Plants from the Indian Sub-Continent. Molecular and Cellular Pharmacology. 3, 21–29
• [41] Thomson M and Ali M (2003). Garlic [Allium sativum]: a review of its potential use as an anticancer agent. Current cancer drug targets. 3, 67–81
• [42] Edward giovannucci, David M Harlan, Michael C Archer, Richard M Bergenstal, Susan M Gapstur, Laurel A Habel, Michael Pollak, Judith G Regensteiner (2010). Diabetes and cancer. Diabetes care. 33, 1674–1685
• [43] Greenwood M, Wood F (1914). The Relation Between the Cancer and Diabetes Death-Rates. J Hyg (Lond). 14, 83–118
• [44] Cignarelli A, Genchi VA, Caruso I, Natalicchio A, Perrini S, Laviola L, et al (2018). Diabetes and Cancer: Pathophysiological Fundamentals of a ‘Dangerous Affair’. Diabetes Res Clin Pract. 143, 378–88
• [45] Livingstone SJ, Levin D, Looker HC, Lindsay RS, Wild SH, Joss N, et al. (2015). Estimated Life Expectancy in a Scottish Cohort with Type 1 Diabetes, 2008-2010. JAMA 313, 37–44
• [46] Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP (2015). Type 2 Diabetes and Cancer: Umbrella Review of Meta-Analyses of Observational Studies. BMJ 350, 7607
• [47] Chen Y, Wu F, Saito E, Lin Y, Song M, Luu HN, et al (2017). Association Between Type 2 Diabetes and Risk of Cancer Mortality: A Pooled Analysis of Over 771,000 Individuals in the Asia Cohort Consortium. Diabetologia 60, 1022–1032
• [48] Gullo L, Pezzilli R and Morselli-Labate AM (1994). Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group. N Engl J Med. 331, 81–84
• [49] Schwarts SS, Zeidler A, Moossa AR, Kuku SF and Rubenstein AH (1978). A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma. Dig Dis. 23, 1107–1114
• [50] Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB and Larsson J (1993). Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg. 165, 61–67
• [51] Fisher WE, Boros LG and Schirmer WJ (1995). Reversal of enhanced pancreatic cancer growth in diabetes by insulin. Surgery. 118, 453–458
• [52] Bowker SL, Majumdar SR, Veugelers P et al (2006). Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care. 29, 254–258
• [53] Yin-Hsun Feng, Guermarie Velazquez-Torres, Christopher Gully, Jian Chen, Mong-Hong Lee, Sai-Ching Jim Yeung (2011). The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J. Cell. Mol. Med. 15, 825–836
• [54] Jiralerspong S, Palla SL, Giordano SH, et al. (2009). Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 27, 3297–3302
• [55] Hirsch HA, Iliopoulos D, Tsichlis PN, et al. (2009). Metformin selectively targets 836 cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res. 69, 7507–7511

• Document Type: article